Clinical Trial Update: EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports results for evaluating the XIENCE V everolimus-eluting stent in patients with multivessel coronary disease; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Restenosis
• Coronary Artery Stenosis

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Disease, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-08-15